Page last updated: 2024-10-17

lactic acid and Whooping Cough

lactic acid has been researched along with Whooping Cough in 4 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Whooping Cough: A respiratory infection caused by BORDETELLA PERTUSSIS and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath.

Research Excerpts

ExcerptRelevanceReference
"Presentation of pertussis toxoid as nano/micro particles (NP/MP) gave similar antigen-specific IgG responses in mice compared to soluble antigen."1.43PLGA nano/micro particles encapsulated with pertussis toxoid (PTd) enhances Th1/Th17 immune response in a murine model. ( Asokanathan, C; Khaing, KK; Kmiec, D; Kong, D; Li, P; Liu, F; Song, B; Wei, X; Xing, D, 2016)
"Purified Bordetella pertussis antigens, encapsulated in biodegradable poly(DL-lactide-co-glycolide) (DL-PLG) microspheres, were evaluated for their immunogenicity and ability to elicit a protective immune response against B."1.29Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres. ( Eldridge, J; Gilley, R; Hudson, M; Leef, M; Shahin, R, 1995)
"Fimbriae from Bordetella pertussis have been encapsulated in poly(lactide-co-glycolide) microparticles of a size appropriate for uptake by the immune inductive tissues of the gastrointestinal tract."1.29Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection. ( Farrar, GH; Jones, DH; McBride, BW; O'Hagan, DT; Robinson, A; Thornton, C, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, P1
Asokanathan, C1
Liu, F1
Khaing, KK1
Kmiec, D1
Wei, X1
Song, B1
Xing, D1
Kong, D1
Shahin, R1
Leef, M1
Eldridge, J1
Hudson, M1
Gilley, R1
Jones, DH1
McBride, BW1
Thornton, C1
O'Hagan, DT1
Robinson, A1
Farrar, GH1
Conway, MA1
Madrigal-Estebas, L1
McClean, S1
Brayden, DJ1
Mills, KH1

Other Studies

4 other studies available for lactic acid and Whooping Cough

ArticleYear
PLGA nano/micro particles encapsulated with pertussis toxoid (PTd) enhances Th1/Th17 immune response in a murine model.
    International journal of pharmaceutics, 2016, Nov-20, Volume: 513, Issue:1-2

    Topics: Animals; Antigens, Bacterial; Bordetella pertussis; Cell Line; Female; Immunoglobulin G; Interferon-

2016
Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres.
    Infection and immunity, 1995, Volume: 63, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antigens, Bacterial; Bacterial Outer Me

1995
Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.
    Infection and immunity, 1996, Volume: 64, Issue:2

    Topics: Administration, Oral; Animals; Bordetella pertussis; Female; Fimbriae, Bacterial; Immunization; Immu

1996
Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
    Vaccine, 2001, Feb-28, Volume: 19, Issue:15-16

    Topics: Adhesins, Bacterial; Administration, Oral; Animals; Antibodies, Bacterial; Antigens, Bacterial; Bioc

2001